Is Rapport Therapeutics, Inc. Common Stock (RAPP) a Buy, Sell, or Hold?
NASDAQ : RAPP
Rapport Therapeutics, Inc. Common Stock — Analyst Ratings
$40.98 USD
-$1.8 (-4.21%)
- Volume
- 232.5K
- Average Volume
- 367.63K
- Market Capitalization
- $1.96B
- P/E Ratio
- -15.76
- Dividend Yield
- 0.00%
- Price Target
- $60.50
- Year High
- $44.28
- Year Low
- $13.62
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $27.08
Analyst Consensus Summary
Consensus Rating
Sell
5 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-32.3%
vs Current Price
Price Target
$60.50
Average TargetPrice Target Range
Lowest Target
$52.00
-21.2% DOWNSIDE
Average Target
$60.50
Median Estimate
Highest Target
$66.00
-37.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 5
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 5 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Raymond James | Tiago Fauth | $66 | $34.1199 | 2026-04-10 05:40 AM | 93.4% |
| BTIG | Kambiz Yazdi | $47 | $29.965 | 2026-03-09 09:49 AM | 56.8% |
| Wells Fargo | Benjamin Burnett | $43 | $26.61 | 2026-02-02 05:58 AM | 61.6% |
| H.C. Wainwright | Douglas Tsao | $40 | $30.16 | 2025-12-09 06:09 AM | 32.6% |
| Truist Financial | Joon Lee | $44 | $24.85 | 2025-09-16 06:11 AM | 77.1% |
| Jefferies | Andrew Tsai | $35 | $25.44 | 2024-07-02 12:51 AM | 37.6% |